Virtual Reality Devices as an Adjunct to Usual Care for Patients With Sickle Cell Disease Experiencing Vaso-Occlusive Crises

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Maryland, Baltimore

About this trial

This study aims to evaluate the use of virtual reality as an adjunct to standard care for patients with sickle cell disease experiencing vaso-occlusive crises.

Eligibility criteria

Qualifiers

Adult (age > 18 years) emergency department patient

History of sickle cell disease

Presenting to the emergency department due to acute pain related to sickle cell disease thought to be due to vaso-occlusive crisis

Disqualifiers

Prior enrollment in this study

Presenting with a chief complaint suggestive of a complicated crisis (such as concern for acute chest syndrome, splenic sequestration, hepatic sequestration, pulmonary embolism) as determined by the clinical care provider

Not being treated with intravenous opioids for the vaso-occlusive crisis

Patients who lack the capacity to provide informed consent

Trial design

Treatments tested in this trial

  • Virtual Reality Headset and Hand-Held Controllers
  • Blindfolding and Noise Cancelling

Treatment groups

30 Participants
are divided into 3 treatment groups